Long-Term Outcome of Sirolimus Rescue in Kidney-Pancreas Transplantation-Reference-Cited by-同舟云学术

Long-Term Outcome of Sirolimus Rescue in Kidney-Pancreas Transplantation

Published:2004-08-27 Issue:4 Volume:78 Page:619-622
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Rogers Jeffrey,Ashcraft Elizabeth E.,Emovon Osemwegie E.,Baillie G Mark,Taber David J.,Marques Ruy G.,Baliga Prabhakar K.,Chavin Kenneth D.,Lin Angello,Afzal Fuad,Rajagopalan P R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference10 articles.

1. Clinical Transplants;Gruessner,1999

2. Immunosuppression in pancreas transplantation: progress, problems and perspective.;Stratta;Transpl Immunol,1998

3. Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients.;Citterlo;Transplant Proc,2003

4. Rapamycin and low-dose tacrolimus in kidney-pancreas recipients: a 12–36 month follow-up (abstract).;MacDonald;Am J Transplant,2002

5. A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation.;Kaufman;Transplantation,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08

2. The current challenges for pancreas transplantation for diabetes mellitus;Pharmacological Research;2015-08

3. Sirolimus in solid organ transplantation: current therapies and new frontiers;Immunotherapy;2011-12

4. Mammalian Target of Rapamycin (mTOR) Inhibitors;Drug Safety;2011-02

5. Conversion to Sirolimus in Kidney–Pancreas and Pancreas Transplantation;Transplantation Proceedings;2008-12